Elsevier

Sleep Medicine

Volume 17, January 2016, Pages 144-148
Sleep Medicine

Original Article
Napping and the risk of type 2 diabetes: a population-based prospective study

https://doi.org/10.1016/j.sleep.2015.11.004Get rights and content

Abstract

Objective

Some studies indicate an association between napping and increased risk of type 2 diabetes. We studied this prospectively in a sample representative of general population.

Methods

A questionnaire was administered to the Finnish Twin Cohort in 1990 (response rate 77%, age 33–60 years). The study population included 12,244 subjects who replied to the question “Do you sleep during the daytime (take naps)?” with five response alternatives ranging from “no need” to “every or almost every day.” Information on incident cases of diabetes was obtained by linkage to nationwide registers. Logistic regression models were used to obtain odds ratios (ORs) (95% confidence intervals) for incident type 2 diabetes risk in 1991–2004 by napping category. Adjustments were made for 11 socio-demographic and lifestyle covariates. For subjects aged 33–45 years at baseline, a questionnaire in 2011 provided information on prevalent diabetes.

Results

Thirty-four per cent had no need for napping, and 15% did so on ≥3 days weekly. There were 356 incident type 2 diabetes cases during the follow-up. Using the ‘no need’ category as the reference, the risk of type 2 diabetes was significantly increased only among those napping most frequently [OR 1.86 (1.29–2.67), age- and sex-adjusted]. After adjusting for other covariates, the results were essentially the same, but when adjusted for body mass index, the association decreased (to about 1.3) and was statistically non-significant. Analysis of 2011 self-reported type 2 diabetes was in line with the register data.

Conclusions

Frequent napping is associated with future risk of type 2 diabetes. This association is largely explained by obesity.

Introduction

A growing number of epidemiological studies have linked sleep disturbances (insufficient sleep, fragmented sleep, circadian dysregulation, and obstructive sleep apnea) with adverse metabolic sequelae, including obesity, insulin resistance, and type 2 diabetes [1]. Also, short sleep (less than 5–6 h per night) and long sleep (8 h or more), as well as insomnia symptoms, are associated with a significantly increased risk of type 2 diabetes [2].

Napping is a common cross-cultural phenomenon occurring across the lifespan and increasing with advancing age [3]. There are, however, no widely accepted definitions or criteria of napping; it usually refers to brief periods of daytime sleep (lasting less than several hours). Naps have also been used as a countermeasure to sleepiness during night shifts at work. In a review of earlier napping literature, Dinges [4] concluded that three-quarters of adults reported napping and the usual duration was from about 30 to 90 min. Later, Pilcher et al. [5] showed in a one-week sleep-log study in a group of young and middle-aged adults that in almost half of them, the average nap lasted less than 20 min (often called power naps).

Napping has been regarded both as a health-promoting habit [3] and as a risk factor, or a proxy, for a variety of chronic conditions [6] and mortality [7]. Among the most notable of these adversities are obesity and metabolic syndrome [8]. Obesity is both a major risk factor for type 2 diabetes [9] and also increases the risk for sleep-disordered breathing, especially obstructive sleep apnea [10]. Furthermore, while excessive daytime sleepiness and need for naps can result from poor sleep, it has also been shown that a shared underlying factor, like chronic stress exposure, both promotes obesity and deteriorates sleep [11].

Contrary to the many studies on other aspects of sleep and metabolic changes, there are only few reports of the association between napping and diabetes [8], [12], [13], [14], [15], fasting hyperglycemia [16], glycated hemoglobin, or insulin resistance [17], respectively. These available studies suggest an association between napping and diabetes (mainly type 2 diabetes) or impaired glucose regulation. However, the direction of possible causation and the existence of known or unknown confounders have been inadequately explored.

In this study we assessed the association between napping and the risk of type 2 diabetes in a large, prospective, population-based cohort of Finnish adult twins, with 14-year follow-up data and detailed information on potential confounding or effect-modifying factors, and information on incident cases of diabetes from nationwide registers. We also examined the association among a subset of twins replying to a follow-up questionnaire. We wanted especially to address the role of obesity in this association.

Section snippets

Population sample

The Older Finnish Twin Cohort is a longitudinal study of Finnish twin pairs of the same gender born before 1958 with both co-twins alive in 1975. These pairs were selected from the Central Population Registry of Finland in 1974 [18]. Zygosity was determined using an accurate and validated questionnaire method [19]. The third questionnaire survey in 1990 was mailed to pairs born in 1930–1957 with both co-twins resident in Finland in 1987, and 16,179 twin individuals could be contacted (response

Results

The distribution of answers to the question on napping was as follows: no need, 34.3%; I would like to but I cannot sleep during the daytime, 15.7%; on two days weekly or more seldom, 35.2%; on three to five days weekly, 7.7%; and every or almost every day, 7.1%. There were no major differences in the distributions between age groups under 40, 40–50, and 50 years or older, respectively. There were no significant differences between the two genders. Details on these as well as distributions of

Discussion

Our results show that the risk for type 2 diabetes was significantly increased among middle-aged individuals who, as much as 14 years earlier, had reported napping daily or almost daily. The association remained essentially the same after adjustments for sleep-related covariates such as insomnia, snoring, or sleep length. However, the association became non-significant after adjusting for BMI, suggesting that napping is not an independent risk factor for type 2 diabetes. This conclusion was

Conflict of interest

The authors report no conflicts of interest.

The ICMJE Uniform Disclosure Form for Potential Conflicts of Interest associated with this article can be viewed by clicking on the following link: http://dx.doi.org/10.1016/j.sleep.2015.11.004.

. ICMJE Form for Disclosure of Potential Conflicts of Interest form.

Acknowledgement

This research was supported by the Academy of Finland (Grant nos. 263278, 265240, and 267882).

References (35)

  • K.-B.H. Lam et al.

    Napping is associated with increased risk of type 2 diabetes: the Guangzhou Biobank Cohort Study

    Sleep

    (2010)
  • M. Lehtovirta et al.

    Evidence that BMI and type 2 diabetes share only a minor fraction of genetic variance: a follow-up study of 23,585 monozygotic and dizygotic twins from the Finnish Twin Cohort Study

    Diabetologia

    (2010)
  • R. Wolk et al.

    Obesity, sleep apnea, and hypertension

    Hypertension

    (2003)
  • E.A. Lucassen et al.

    The hypothalamic-pituitary-adrenal axis, obesity, and chronic stress exposure: sleep and the HPA axis in obesity

    Curr Obes Rep

    (2012)
  • S.E. Goldman et al.

    Association between nighttime sleep and napping in older adults

    Sleep

    (2008)
  • J.L. Picarsic et al.

    Self-reported napping and duration and quality of sleep in the lifestyle interventions and independence for elders pilot study

    J Am Geriatr Soc

    (2008)
  • XuQ. et al.

    Day napping and short night sleeping are associated with higher risk of diabetes in older adults

    Diabetes Care

    (2010)
  • Cited by (0)

    View full text